New York, July 01, 2016 (GLOBE NEWSWIRE) -- According to new report by Persistence Market Research - The global non-invasive prenatal testing (NIPT) market was valued at US$ 0.8 Bn in 2015 and is expected to grow at a year-over-year rate of 29.8% to reach US$ 1.1 Bn in 2016. North America will continue to be the most lucrative market, accounting for over 50% shareof the global non-invasive prenatal testing market in 2016. North America’s dominance of the global market will be fueled by numerous factors, prime among them being the presence of major NIPT producing companies in U.S. Asia Pacific, the second-largest market for non-invasive prenatal testing, will grow by 39.0% in 2016 to reach 0.2 Bn in revenues.
High incidence rate of babies born with Down syndrome, and increasing preference for late pregnancy due to lifestyle and thereby increasing risk of developing a fetus with certain chromosomal aneuploidies are considered as major growth engines for NIPT market during the forecast period.
On the other hand, factors such as government regulatory guidelines, ethical hurdles with regards to invasive confirmatory prenatal tests, and test presumptions which may lead to higher abortion rates may curtail the global NIPT market. Few prominent healthcare institutions and research centers have recommended the use of NIPT only in case of high-risk pregnancy.
On the basis of test types the global non-invasive prenatal testing is segmented into BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi and VisibiliT. The NIPT market is largely confined within these major test types. However, manufacturers are focusing on developing more innovative technologies and testing methods.
For more info: Get the sample report@http://www.persistencemarketresearch.com/samples/11218
Region-wise, the global NIPT market is segmented into North America, Europe, Asia Pacific (APAC) and Rest of World (ROW). As discussed previously, North America and Asia Pacific are the most lucrative markets for NIPT globally, and will continue to maintain their dominance in 2016 and beyond.
Key participants in the global NIPT market include Sequenom, Inc,Ariosa Diagnostics, LabCorp, BGI Diagnostics, LifeCodexx AG, Verinata Health (Illumina, Inc.), Natera, Inc, Laboratoire Cerba, Berry Genomics co. ltd, DASA Group, Fleury Group and Israelita Albert Einstein (hospital). These key players are focusing on developing cutting-edge products and expansion into new markets to consolidate their position.
Note to Members of the Press: Editors and journalists who have compiled this report are available for interviews and quotes email@example.com
Summary: Market research report on the global non-invasive prenatal testing market. Adoption of prenatal testing highest in North America, followed by Asia Pacific.
The Contents and Layout of Research Report:http://www.persistencemarketresearch.com/market-research/non-invasive-prenatal-testing-nipt-market.asp
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 United States USA - Canada Toll-Free: 800-961-0353 Email: firstname.lastname@example.org Web: http://www.persistencemarketresearch.com LinkedIn: https://www.linkedin.com/company/persistence-market-research-&-consulting Twitter: https://twitter.com/persistence_mkt
Source:Persistence Market Research